Approximately 117,800 kilograms of Chlorhexidine Gluconate (an active pharmaceutical ingredient) are being recalled because the bacteria Serratia marcescens was detected in certain batches. This product is a prescription drug component used for manufacturing, processing, or repacking medicinal products. Consumers and healthcare providers should be aware that the presence of this bacteria in non-sterile products can lead to serious infections, especially in vulnerable populations. This recall involves multiple batches distributed nationwide with expiration dates ranging from September 2021 to March 2022.
The product is contaminated with Serratia marcescens, a gram-negative bacillus that can cause healthcare-associated infections, including urinary tract infections, wound infections, and pneumonia. If used in the preparation of medical products, this contamination poses a significant risk of illness or infection to patients.
Drug product refund and consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.